Nuvectis Pharma Stock Price History
NVCT Stock | USD 9.44 0.05 0.53% |
If you're considering investing in Nuvectis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Nuvectis Pharma stands at 9.44, as last reported on the 19th of March, with the highest price reaching 9.50 and the lowest price hitting 8.81 during the day. Nuvectis Pharma is slightly risky given 3 months investment horizon. Nuvectis Pharma has Sharpe Ratio of 0.25, which conveys that the firm had a 0.25 % return per unit of risk over the last 3 months. We were able to break down thirty different technical indicators, which can help you to evaluate if expected returns of 1.32% are justified by taking the suggested risk. Use Nuvectis Pharma Risk Adjusted Performance of 0.2306, downside deviation of 4.11, and Mean Deviation of 3.94 to evaluate company specific risk that cannot be diversified away.
Nuvectis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Nuvectis |
Sharpe Ratio = 0.2526
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | NVCT | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.24 actual daily | 46 54% of assets are more volatile |
Expected Return
1.32 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
0.25 actual daily | 19 81% of assets perform better |
Based on monthly moving average Nuvectis Pharma is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nuvectis Pharma by adding it to a well-diversified portfolio.
Nuvectis Pharma Stock Price History Chart
There are several ways to analyze Nuvectis Stock price data. The simplest method is using a basic Nuvectis candlestick price chart, which shows Nuvectis Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 17, 2025 | 9.49 |
Lowest Price | December 20, 2024 | 4.52 |
Nuvectis Pharma March 19, 2025 Stock Price Synopsis
Various analyses of Nuvectis Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Nuvectis Stock. It can be used to describe the percentage change in the price of Nuvectis Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Nuvectis Stock.Nuvectis Pharma Price Action Indicator | 0.26 | |
Nuvectis Pharma Price Rate Of Daily Change | 0.99 | |
Nuvectis Pharma Price Daily Balance Of Power | (0.07) |
Nuvectis Pharma March 19, 2025 Stock Price Analysis
Nuvectis Stock Price History Data
Open | High | Low | Close | Volume | ||
03/19/2025 | 9.50 | 9.50 | 8.81 | 9.44 | ||
03/18/2025 | 9.50 | 9.50 | 8.81 | 9.44 | 131,729 | |
03/17/2025 | 9.17 | 9.75 | 8.97 | 9.49 | 222,835 | |
03/14/2025 | 8.48 | 8.99 | 8.25 | 8.85 | 120,677 | |
03/13/2025 | 7.66 | 8.49 | 7.55 | 8.35 | 85,130 | |
03/12/2025 | 7.27 | 7.93 | 7.24 | 7.74 | 80,337 | |
03/11/2025 | 7.62 | 7.90 | 7.01 | 7.33 | 86,319 | |
03/10/2025 | 6.87 | 7.99 | 6.80 | 7.62 | 167,482 | |
03/07/2025 | 6.05 | 6.95 | 6.00 | 6.93 | 82,264 | |
03/06/2025 | 6.21 | 6.45 | 6.06 | 6.15 | 91,393 | |
03/05/2025 | 6.40 | 6.48 | 6.16 | 6.35 | 32,781 | |
03/04/2025 | 6.05 | 6.50 | 5.87 | 6.34 | 69,550 | |
03/03/2025 | 6.61 | 6.75 | 6.09 | 6.14 | 105,700 | |
02/28/2025 | 6.70 | 6.85 | 6.50 | 6.69 | 28,207 | |
02/27/2025 | 6.93 | 6.93 | 6.60 | 6.71 | 47,000 | |
02/26/2025 | 7.13 | 7.36 | 6.81 | 6.86 | 52,325 | |
02/25/2025 | 7.26 | 7.35 | 6.82 | 6.93 | 97,800 | |
02/24/2025 | 7.70 | 7.75 | 7.23 | 7.36 | 59,498 | |
02/21/2025 | 7.57 | 7.89 | 7.42 | 7.59 | 91,419 | |
02/20/2025 | 7.85 | 7.85 | 7.38 | 7.52 | 84,155 | |
02/19/2025 | 7.84 | 8.06 | 7.69 | 7.85 | 95,750 | |
02/18/2025 | 7.75 | 8.13 | 7.62 | 7.74 | 190,100 | |
02/14/2025 | 6.99 | 7.83 | 6.91 | 7.80 | 220,500 | |
02/13/2025 | 6.83 | 7.00 | 6.73 | 6.95 | 147,945 | |
02/12/2025 | 6.38 | 6.90 | 6.30 | 6.86 | 112,200 | |
02/11/2025 | 6.12 | 6.40 | 6.12 | 6.29 | 54,546 | |
02/10/2025 | 6.78 | 6.78 | 6.33 | 6.33 | 93,200 | |
02/07/2025 | 7.25 | 7.40 | 6.56 | 6.71 | 180,400 | |
02/06/2025 | 7.15 | 7.28 | 6.97 | 7.24 | 162,719 | |
02/05/2025 | 6.06 | 7.50 | 6.05 | 7.15 | 495,929 | |
02/04/2025 | 6.82 | 8.00 | 6.74 | 7.00 | 220,100 | |
02/03/2025 | 6.75 | 7.00 | 6.38 | 6.80 | 77,900 | |
01/31/2025 | 6.86 | 6.89 | 6.57 | 6.76 | 42,300 | |
01/30/2025 | 6.45 | 6.74 | 6.33 | 6.74 | 30,400 | |
01/29/2025 | 6.44 | 6.49 | 6.12 | 6.37 | 47,800 | |
01/28/2025 | 6.75 | 7.06 | 6.32 | 6.38 | 123,300 | |
01/27/2025 | 6.38 | 6.79 | 6.32 | 6.73 | 67,400 | |
01/24/2025 | 6.49 | 7.15 | 6.30 | 6.55 | 203,500 | |
01/23/2025 | 6.10 | 6.70 | 6.10 | 6.42 | 138,319 | |
01/22/2025 | 5.68 | 6.10 | 5.65 | 6.10 | 40,152 | |
01/21/2025 | 5.57 | 5.95 | 5.51 | 5.71 | 93,907 | |
01/17/2025 | 5.66 | 5.66 | 5.40 | 5.49 | 34,922 | |
01/16/2025 | 5.37 | 5.56 | 5.34 | 5.46 | 33,513 | |
01/15/2025 | 5.71 | 5.75 | 5.36 | 5.37 | 82,185 | |
01/14/2025 | 5.90 | 5.90 | 5.46 | 5.64 | 33,651 | |
01/13/2025 | 5.80 | 6.08 | 5.46 | 5.81 | 121,153 | |
01/10/2025 | 6.15 | 6.29 | 5.76 | 5.81 | 70,719 | |
01/08/2025 | 6.28 | 6.39 | 5.90 | 6.17 | 79,186 | |
01/07/2025 | 6.52 | 6.75 | 6.00 | 6.23 | 163,663 | |
01/06/2025 | 5.77 | 6.75 | 5.57 | 6.61 | 251,286 | |
01/03/2025 | 5.51 | 5.80 | 5.40 | 5.58 | 178,783 | |
01/02/2025 | 5.45 | 5.89 | 5.33 | 5.39 | 111,728 | |
12/31/2024 | 5.25 | 5.61 | 5.15 | 5.41 | 63,048 | |
12/30/2024 | 5.19 | 5.30 | 5.03 | 5.14 | 112,817 | |
12/27/2024 | 4.88 | 5.44 | 4.85 | 5.22 | 103,073 | |
12/26/2024 | 4.72 | 5.14 | 4.55 | 5.02 | 102,083 | |
12/24/2024 | 4.58 | 4.70 | 4.54 | 4.65 | 38,684 | |
12/23/2024 | 4.63 | 4.78 | 4.44 | 4.58 | 120,800 | |
12/20/2024 | 4.66 | 4.82 | 4.44 | 4.52 | 164,235 | |
12/19/2024 | 4.76 | 4.95 | 4.63 | 4.69 | 89,808 | |
12/18/2024 | 5.13 | 5.19 | 4.48 | 4.70 | 127,767 |
About Nuvectis Pharma Stock history
Nuvectis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nuvectis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nuvectis Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nuvectis Pharma stock prices may prove useful in developing a viable investing in Nuvectis Pharma
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company was incorporated in 2020 and is based in Fort Lee, New Jersey. Nuvectis Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people.
Nuvectis Pharma Stock Technical Analysis
Nuvectis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Nuvectis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nuvectis Pharma's price direction in advance. Along with the technical and fundamental analysis of Nuvectis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nuvectis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.2306 | |||
Jensen Alpha | 1.37 | |||
Total Risk Alpha | 1.89 | |||
Sortino Ratio | 0.3433 | |||
Treynor Ratio | 2.1 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.